ArticleTranslational andrology and urology2026
Long-term survival prognosis and risk stratification after radical cystectomy with Mainz Pouch II urinary diversion: a retrospective cohort study and prognostic model construction.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite its clinical utility, specific long-term prognostic factors for radical cystectomy (RC) with Mainz Pouch II diversion remain unclear. We aimed to identify key overall survival (OS) predictors and construct an algorithmically optimized prognostic nomogram. Methods: We retrospectively analyzed 309 patients who underwent RC with Mainz Pouch II diversion (2004-2023). Regularized Elastic Net regression was evaluated against traditional Cox models and machine learning algorithms (e.g., XGBoost, random survival forest). Predictive performance was comprehensively validated via 10-fold cross-validation and 1,000-sample bootstrap resampling, evaluated by time-dependent area under the curve (AUC), calibration curves, and decision curve analysis (DCA). Results: Advanced age [hazard ratio (HR), 1.03; P=0.001], elevated lymph node density (LND) (HR 8.13, P=0.03), and advanced pathological T stage (T3: HR 2.75; T4: HR 3.94) emerged as significant independent prognostic factors. Binary lymph node metastasis showed only marginal significance (P=0.08), while other features (e.g., tumor grade, lymphovascular invasion, surgical margins) lacked independent predictive value. By mitigating the pronounced overfitting bias observed in complex nonlinear models, the Elastic Net model achieved the highest optimism-corrected Concordance Index (C-index) (0.712) with excellent 5-year calibration. The derived nomogram effectively stratified patients into low-, intermediate-, and high-risk groups with highly distinct survival trajectories (P<0.001). Conclusions: Advanced age, elevated LND, and advanced T stage are the core drivers of long-term OS in this cohort. Built upon the optimal Elastic Net algorithm, the derived nomogram achieved a moderate optimism-corrected C-index (0.712). While it demonstrates risk stratification potential, its current utility is strictly exploratory, requiring rigorous external validation prior to any clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.